Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma

Uveal melanoma is the most common intraocular tumor in adults, representing approximately 5% of all melanoma cases. Up to 50% of uveal melanoma patients develop metastases that are resistant to most of the commonly used antineoplastic treatments. Virtually all uveal melanoma tumors harbor activating...

Descripción completa

Detalles Bibliográficos
Autores principales: Glinkina, Kseniya A., Teunisse, Amina F.A.S., Gelmi, Maria Chiara, de Vries, Jelle, Jager, Martine J., Jochemsen, Aart G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles: Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470438/
https://www.ncbi.nlm.nih.gov/pubmed/37467061
http://dx.doi.org/10.1097/CMR.0000000000000911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470438/
https://www.ncbi.nlm.nih.gov/pubmed/37467061
http://dx.doi.org/10.1097/CMR.0000000000000911

Ejemplares similares